Vaccines against serious Covid diseases are on everyone’s lips. The EMA is now releasing two further drugs for the EU. One thing probably helps against the Omikron variant.
Munich – The numerous vaccines are getting more and more support in the fight against the corona pandemic *. Because the EU drug authority EMA is clearing the way for the approval of two more drugs for the treatment of Covid-19. The EMA announced on Thursday in Amsterdam that patients could be treated well with Xevudy and Kineret.
The EU Commission has yet to approve the approval. But that is a matter of form. With these two preparations, a total of five drugs for the treatment of Covid 19 patients will then be approved in the EU *. Xevudy (sotrovimab) from GlaxoSmithKline and Vir Biotechnology * is a monoclonal antibody. According to the experts, it can prevent a worsening of the condition in patients aged twelve and over.
Video: What use are drugs against Long Covid?
Drug against Covid: Xevudy probably also effective against Omikron
Laboratory studies indicated that Xevudy was also effective against the Omikron variant. The EMA experts had previously expressed a positive opinion about the product, so that it is already being prescribed in some EU member states.
The preparation Kineret can be given to patients with pneumonia who need oxygen. It is already approved in the EU as a remedy for other inflammations. According to the EMA, the product from the Swedish manufacturer Orphan Biovitrum AB can also reduce inflammation in Covid 19 patients and prevent severe damage to the airways.
The European Commissioner for Health, Stella Kyriakides, welcomed the EMA’s recommendation. This means that a wider range of drugs is now available. More would follow in the next few months. (dpa) * Merkur.de is an offer from IPPEN.MEDIA
